[account_shop_links]
Biosimilars in the US Oncology Market (2nd Edition)
$960.00 – $1,920.00
Licensing Options
- SINGLE-USER LICENSE
A Single-User License allows access to an individual user.
- ENTERPRISE-WIDE LICENSE
An Enterprise-Wide License allows access to all employees and sites within an organization.
Report Overview
This report provides data and insights from 101 US-based, board-certified oncologists or hematologist oncologists as to their expectations, fears, and aspirations for biosimilars in oncology.
Use the data contained in this report to better understand how US-based oncologists will make prescribing decisions in a marketplace that includes biosimilar oncology options and how this has changed since 2012.
What you will learn:
- Familiarity with biosimilars
- Expected pricing/discount levels
- Preferred primary endpoints
- Influence the manufacturer plays in the prescribing decision
- How the data have changed since 2012
How you can use this report:
- Use this report to inform your market access strategies, reimbursement plans, and manufacturing capacity planning.
- Better inform your sales and marketing efforts by understanding the benefits and barriers physicians see in prescribing biosimilars.
